Sanofi Q2 2024 Results. Check out sanofi india q2 result news, sanofi india q2 earnings result updates and highlights. In q2 2024, we expect dupixent on the new pharma launches to grow further, while we continue to see the impact of the aubagio loss of exclusivity in europe.
Reported eps is $0.96 eps, expectations. The company said sales were driven by.
Check out sanofi india q2 result news, sanofi india q2 earnings result updates and highlights.
In Q2 2024, We Expect Dupixent On The New Pharma Launches To Grow Further, While We Continue To See The Impact Of The Aubagio Loss Of Exclusivity In Europe.
The company said it had net income of 50 cents per share.
Our Q2 2023 Financial Results Are Now Available.
Images References :
Get The Key Information Of Sanofi India Q1, Q2, Q3 And Q4 Results, Previous Quarterly Results, Quarterly Earnings And Comparison On Economic.
Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on july 25 th, 2024.
In Q2 2024, We Expect Dupixent On The New Pharma Launches To Grow Further, While We Continue To See The Impact Of The Aubagio Loss Of Exclusivity In Europe.
Second quarter 2020 results were reviewed by management during a conference call with the financial.